國立虎尾科技大學 |

Treatment of Inflammatory Bowel Disease with Biologics

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Treatment of Inflammatory Bowel Disease with Biologics / edited by Adam S. Cheifetz, Joseph D. Feuerstein.
其他作者:	Cheifetz, Adam S.
面頁冊數:	XI, 335 p. 22 illus., 19 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Gastroenterology . -
電子資源:	https://doi.org/10.1007/978-3-319-60276-9
ISBN:	9783319602769

Treatment of Inflammatory Bowel Disease with Biologics
Treatment of Inflammatory Bowel Disease with Biologics [electronic resource] /edited by Adam S. Cheifetz, Joseph D. Feuerstein. - 1st ed. 2018. - XI, 335 p. 22 illus., 19 illus. in color.online resource.

Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn’s Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn’s Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics – Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies. .

This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn’s disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.

ISBN: 9783319602769

Standard No.: 10.1007/978-3-319-60276-9doiSubjects--Topical Terms:

1254565
Gastroenterology .

LC Class. No.: RC799-869

Dewey Class. No.: 616.33

Treatment of Inflammatory Bowel Disease with Biologics
LDR:03301nam a22003975i 4500 001 993266
003 DE-He213
005 20200705171156.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319602769 $9 978-3-319-60276-9
024 7 $a 10.1007/978-3-319-60276-9 $2 doi
035 $a 978-3-319-60276-9
050 4 $a RC799-869
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.33 $2 23
245 1 0 $a Treatment of Inflammatory Bowel Disease with Biologics $h [electronic resource] / $c edited by Adam S. Cheifetz, Joseph D. Feuerstein.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XI, 335 p. 22 illus., 19 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn’s Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn’s Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics – Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies. .
520 $a This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn’s disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
650 0 $a Gastroenterology . $3 1254565
650 1 4 $a Gastroenterology. $3 673684
700 1 $a Cheifetz, Adam S. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228566
700 1 $a Feuerstein, Joseph D. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1228565
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319602752
776 0 8 $i Printed edition: $z 9783319602776
776 0 8 $i Printed edition: $z 9783319868233
856 4 0 $u https://doi.org/10.1007/978-3-319-60276-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)